Physician profile
Behnum Habibi
NPI 1548656770
$3,241.32
in general payments reported to CMS, 2019-2025
12 companies · $2,595 in 2025
The $2,595 reported for 2025 was more than what 89% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2021: $187 · 2023: $94.73 · 2024: $179 · 2025: $2,595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,507 · Consulting Fee: $1,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,506.64 |
| Consulting Fee | $1,362.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $1,807.81 | 2024-2025 | Prospera |
| Medtronic, INC. | $358.32 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Saluda Medical Americas, INC. | $241.88 | 2025 | Evoke |
| Nevro Corp. | $186.55 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $136.14 | 2025 | |
| Globus Medical, INC. | $112.50 | 2025 | Senza |
| Teva Pharmaceuticals USA, INC. | $106.13 | 2019 | |
| Nalu Medical, INC. | $97.00 | 2025 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $80.00 | 2019 | |
| Abbott Laboratories | $53.73 | 2025 | Eterna |
| Piramal Critical Care | $32.64 | 2025 | |
| Spr Therapeutics, INC | $28.62 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Behnum Habibi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.